Ticker brief
ACHV
last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
12
authors 14d
8
No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.
Sentiment — last 14 days
daily mean sentiment, 2026-06-22 → 2026-07-01 · now +0.25 (−1 bearish … +1 bullish)
Who spoke8
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @Ahmedalsamel1 | C | -1.23 | 3 | +0.17 |
| @Omnitrader69 | C | -1.20 | 2 | +0.50 |
| @BiopharmIQ | B | · | 2 | -0.40 |
| @BioStocks | C | -0.39 | 1 | -0.45 |
| @CrweWorld | C | · | 1 | -0.50 |
| @OptionsFlowBoss | C | · | 1 | +0.00 |
| @OpenOutcrier | C | · | 1 | +0.30 |
| @Maximus_Holla | C | -0.48 | 1 | +0.25 |
Recent signals12of 12 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-07-01 | @Ahmedalsamel1 | +0.25 | Mentions ACHV 14% with link, likely performance recap. | · | tweet ↗ |
| 2026-07-01 | @Maximus_Holla | +0.25 | Past-tense comment that ACHV kept running without readd chance. | · | tweet ↗ |
| 2026-06-28 | @Ahmedalsamel1 | +0.00 | Arabic post says ACHV is under watch, with chart context only. | · | tweet ↗ |
| 2026-06-27 | @Ahmedalsamel1 | +0.25 | ACHV weekly chart has a notable head-and-shoulders pattern. | · | tweet ↗ |
| 2026-06-26 | @OpenOutcrier | +0.30 | Lists 6/26 positive coverage initiations; capped to first six tickers. | · | tweet ↗ |
| 2026-06-26 | @OptionsFlowBoss | +0.00 | Mentions OI changes for ACHV without direction. | · | tweet ↗ |
| 2026-06-25 | @Omnitrader69 | +0.35 | Notes interesting call buys and sudden push to 6. | · | tweet ↗ |
| 2026-06-22 | @CrweWorld | -0.50 | Achieve Life Sciences receives FDA Complete Response Letter for Cytisinicline NDA. | · | tweet ↗ |
| 2026-06-22 | @BiopharmIQ | -0.35 | Biotech stock moves list with percentage changes and associated clinical/regulatory headlines. | · | tweet ↗ |
| 2026-06-22 | @BiopharmIQ | -0.45 | ACHV receives FDA CRL for cytisinicline NDA, with Q4 2026 resubmission planned. | · | tweet ↗ |
| 2026-06-22 | @Omnitrader69 | +0.65 | Says expected FDA issue is addressable and ACHV will get approved. | · | tweet ↗ |
| 2026-06-22 | @BioStocks | -0.45 | ACHV receives FDA CRL for cytisinicline NDA due to third-party manufacturing deficiencies. | · | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.